Cargando…
Off-label drugs for weight management
The global pandemic of obesity and overweight now affects between 2.8 and 3.5 billion of the world population and shows no signs of abatement. Treatment for what is now recognized as a chronic disease includes pharmacotherapy, considered an essential component of comprehensive therapy. New drug disc...
Autor principal: | Hendricks, Ed J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473499/ https://www.ncbi.nlm.nih.gov/pubmed/28652791 http://dx.doi.org/10.2147/DMSO.S95299 |
Ejemplares similares
-
Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022) -
The evolving role and utility of off-label drug use in multiple myeloma
por: Stoeckle, James H, et al.
Publicado: (2021) -
Guideline for the management of pediatric off-label use of drugs in China (2021)
por: Meng, Min, et al.
Publicado: (2022) -
Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023) -
Regulating off-label drug use in India: The arena for concern
por: Oberoi, Sukhvinder Singh
Publicado: (2015)